Health Atossa Therapeutics Receives Approval from Swedish Regulators to Initiate Phase 2 Clinical Study of… James Pereira Jun 13, 2021 SEATTLE, June 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage… Read More...
